The Relationship of Spine Posture and Mobility With Upper Extremity Functions in Parkinson's Patients
Investigation of the Relationship of Spinal Alignment and Spinal Mobility on Upper Extremity Functions and Quality of Life in Patients With Parkinson's Disease.
1 other identifier
observational
60
1 country
1
Brief Summary
The aim of this study is to investigate whether spinal alignment and spinal mobility have an effect on upper extremity functions in Parkinson's patients. In the light of the data obtained as a result, we think that our study will also contribute to determining the factors that may cause upper limb dysfunctions seen in Parkinson's patients and will guide new treatment-oriented studies to be carried out in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2021
CompletedStudy Start
First participant enrolled
November 3, 2021
CompletedFirst Posted
Study publicly available on registry
November 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2022
CompletedJuly 8, 2022
July 1, 2022
3 months
November 3, 2021
July 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Spinal Mouse
This device is an electronic computer aided measuring device that measures the range of motion of the spine and evaluates the angle and shape of the spine in the sagittal and frontal planes. The device provides data to the computer via Bluetooth and the measured curvatures are displayed on the computer screen. The method has no medical risk or danger. The device has two rotating wheels that follow the spinous processes of the spine and the distance and angle measurements are transferred from the device to the computer. This information is then used to calculate the relative positions of each vertebra, the angles between the vertebrae, and the total angle of the frontal and sagittal plane curvatures with its software.
Measurements will begin on the estimated 3 November and will end on the estimated June 2022.
Secondary Outcomes (1)
Nine Hole Peg Test
Measurements will begin on the estimated 3 November and will end on the estimated June 2022.
Other Outcomes (1)
Parkinson's Disease Questionnaire (PDQ-8)
Measurements will begin on the estimated 3 November and will end on the estimated June 2022.
Study Arms (2)
Parkinson's patients
The cognitive status of the participants will be evaluated using the 'Standardized Mini Mental Test'. The 'Unified Parkinson's Disease Assessment Scale Part 3' will be used to evaluate the motor function of Parkinson's patients. Spinal posture will be assessed using the IDIAG M360 (IDIAG, Fehraltorf, Switzerland) Spinal Mouse. This device is an electronic computer aided measuring device that measures the range of motion of the spine and evaluates the angle and shape of the spine in the sagittal and frontal planes. The upper extremity functions of Parkinson's patients will be evaluated with the '9-Hole Peg Test'. A short version of PDQ-39, called the 8-item Parkinson's Disease Questionnaire (PDQ-8), will be applied to determine the quality of life of Parkinson's patients. The PDQ-8 consists of eight items that belong to each of the eight dimensions in the original PDQ-39.
Healthy control group
The cognitive status of the participants will be evaluated using the 'Standardized Mini Mental Test'. This scale is frequently used for the general determination of the cognitive status of individuals rather than for the purpose of diagnosis. The upper extremity functions of healty control group will be evaluated with the '9-Hole Peg Test'. Spinal posture will be assessed using the IDIAG M360 (IDIAG, Fehraltorf, Switzerland) Spinal Mouse. This device is an electronic computer aided measuring device that measures the range of motion of the spine and evaluates the angle and shape of the spine in the sagittal and frontal planes.
Interventions
This device is an electronic computer-aided measuring december that measures the range of motion of the spine, evaluates the angle and shape of the spine in the sagittal and frontal planes. The device provides data to the computer via Bluetooth, and the measured curvatures are displayed on the computer screen. The method has no medical risks or dangers. The device has two rotating wheels that follow the spinous protrusions of the spine, and the distance and angle measurements are transferred from the device to the computer.
The nine-hole peg test is a simple, fast and manual skill test that has been proven to be valid and reliable in measuring upper limb function in Parkinson's patients. While the patient is sitting, he is asked to insert nine sticks into the holes of the test box with nine holes one by one as fast as possible and remove them back when he is finished
Eligibility Criteria
Healthy individuals with similar age and body mass index values for Parkinson's patients who were diagnosed with Parkinson's disease according to the UK Parkinson's Disease Association Brain Bank criteria, followed in the Health Sciences University Gülhane Training and Research Hospital Neurology Department Parkinson's Polyclinic, and the control group will be included in the study.
You may qualify if:
- For Parkinson's Patients;
- Being 18 years or older
- Receiving a diagnosis of Parkinson's made by a specialist neurologist
- Being able to walk independently
- Being between stages 1-4 on the Hoehn \& Yahr scale
- For the Control Group;
- Being 18 years or older
You may not qualify if:
- For Parkinson's Patients;
- Having any neurological disease other than Parkinson's
- Presence of cardiovascular, vestibular and musculoskeletal disease
- Having a score of \<24 on the Standardized Mini Mental Test
- For the Control Group;
- Having any disease that may affect balance, gait, posture and respiratory functions
- Using sedative - antidepressant medication that will impair physical well-being
- Having a score of \<24 on the Standardized Mini Mental Test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sağlık Bilimleri Üniversitesi
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof
Study Record Dates
First Submitted
November 3, 2021
First Posted
November 15, 2021
Study Start
November 3, 2021
Primary Completion
February 3, 2022
Study Completion
June 15, 2022
Last Updated
July 8, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share